![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_010ff3533be73eb2f6c337843abe1f0d.svg) | O6-Cyclohexylmethoxy-2-(4'-sulphamoylanilino) purine | IC50 | 80.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_85bfeb5c1c0028708a30ec66fc1bbd21.svg) | Seliciclib | IC50 | 500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_b235fdd282a483b68a6f43230cd106de.svg) | 4-Nitro-2-{[4-(methylsulfanyl)benzylidene]amino}phenol | IC50 | 69800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_000b8ce6322fa44973ae7360b2e38f90.svg) | Olomoucine | IC50 | 7000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_1d5eba4b4bb57896dda18b1604bab021.svg) | Staurosporine | IC50 | 0.1 [1], 0.36 [2], 1.4 [3], 2.6 [4], 3.8 [5] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_3018143d9ec777a5d1640803f50be529.svg) | Alvocidib | IC50 | 40.0 [1], 170.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_3018143d9ec777a5d1640803f50be529.svg) | Alvocidib | Ki | 190.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_e7902e795bb889d9776f6a7fbe9f7e96.svg) | Purvalanol A | IC50 | 4.0 [1], 35.0 [2], 70.0 [3] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_2cca4de95be713540290376251727bc4.svg) | Sns-032 | IC50 | 38.0 [1], 46.0 [2], 48.0 [3] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_2cca4de95be713540290376251727bc4.svg) | Sns-032 | Ki | 38.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_4191d8271c12eb643a9c00f600686e69.svg) | 6-O-Cyclohexylmethyl guanine | IC50 | 17000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_4191d8271c12eb643a9c00f600686e69.svg) | 6-O-Cyclohexylmethyl guanine | Ki | 1200.0 [1], 12000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_029ad025c39fc49c6b03b60ea42a3fff.svg) | Cdk2 Inhibitor II | IC50 | 60.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_18e8c1acc3a35c83e738f442c888cf01.svg) | Oxindole-Based Inhibitor 20 | IC50 | 30.0 [1], 43.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_c4afaf473ae503e57f9bfa0fbb0861da.svg) | 2-(2-Chloro-N-[6-[4-[(2S)-3-(dimethylamino)-2-hydroxypropoxy]anilino]pyrimidin-4-yl]-5-methylanilino)acetonitrile | IC50 | 140.0 [1], 640.0 [2], 2600.0 [3], 7300.0 [4] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_bbd8a6326d177ae3f285e1f4ecb09141.svg) | Dinaciclib | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_529828b056b2f30ac4801342ca43d9f7.svg) | (3Z)-3-(1H-Imidazol-5-ylmethylene)-5-methoxy-1H-indol-2(3H)-one | IC50 | 22.0 [1], 35.0 [2], 110.0 [3] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_6adf5f7add3d7dfb1f36fd6e40532726.svg) | 6-Cyclohexylmethyloxy-5-nitroso-pyrimidine-2,4-diamine | IC50 | 2200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_6adf5f7add3d7dfb1f36fd6e40532726.svg) | 6-Cyclohexylmethyloxy-5-nitroso-pyrimidine-2,4-diamine | Ki | 1300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_bebc2451b47118c8850e198238189c40.svg) | 4-(1-Isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine | IC50 | 6.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_495c00c0eebcec0612a883578e83da0a.svg) | Milciclib | IC50 | 45.0 [1], 363.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_425c10a898515c91fc37f29e65a208d5.svg) | 4-[(7-Hydroxy-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-yl)methylideneamino]-N-pyridin-2-ylbenzenesulfonamide | IC50 | 9.7 [1], 10.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_90800ae1f1a12931d9a5139eb471150b.svg) | Oxindole-Based Inhibitor 29 | IC50 | 1.5 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_95c3d43343f5f52e38155588c7cc676c.svg) | Oxindole-Based Inhibitor 22 | IC50 | 2.3 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_8f49deac78f96575a3d73a5eb3dc5d3a.svg) | 4-[1-(2-Hydroxy-1H-indol-3-yl)ethylideneamino]benzenesulfonamide | IC50 | 360.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_8479f7789dbadc6e13ec935138c740de.svg) | 4-[[5-(Dimethylamino)-2-hydroxy-1H-indol-3-yl]methylideneamino]benzenesulfonamide | IC50 | 310.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_7a5b005137eee936f5dfd99c228c5664.svg) | 4-[(7-Hydroxy-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-yl)methylideneamino]benzenesulfonamide | IC50 | 2.8 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_68c9f9adebf5c52a95b15f2fd1d0bf0d.svg) | Oxindole-Based Inhibitor 60 | IC50 | 8.9 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_bf161aed1df6c4d001431e4a9d48593d.svg) | Oxindole-Based Inhibitor 66 | IC50 | 75.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_c3c7c37f8d9b3bde3c6f967947b11433.svg) | Oxindole-Based Inhibitor 43 | IC50 | 46.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_770f989b1f3dfea2d0a8b84d69f587fe.svg) | TrkA Inhibitor | IC50 | 690.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_eead083d9a3f02c87c63aebdc04080ee.svg) | Oxindole-Based Inhibitor 27 | IC50 | 2.5 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_2ac244d7078e47c2b64cfdfa151359ce.svg) | Oxindole-Based Inhibitor 31 | IC50 | 3.4 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_0718c955dcd00018cd045a0b24529602.svg) | Oxindole-Based Inhibitor 49 | IC50 | 16.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_56f165a9821b6843e1ba6e7a04941cff.svg) | Oxindole-Based Inhibitor 50 | IC50 | 43.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_94e02ba78e5a1da9890f5a258e47e328.svg) | Oxindole-Based Inhibitor 56 | IC50 | 4.5 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_586f1f7fd7a8f726adbc6782a5eab010.svg) | [4-(2-Amino-4-methyl-thiazol-5-YL)-pyrimidin-2-YL]-(3-nitro-phenyl)-amine | Ki | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_7dbb58bf14e32aca63d114717847d632.svg) | 1-(Dimethylamino)-3-[4-[[4-(2-methylimidazo[1,2-a]pyridin-3-yl)pyrimidin-2-yl]amino]phenoxy]propan-2-ol | IC50 | 1.0 [1], 10.0 [2], 32.0 [3] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_79ccba98dd462b1631c9db41481af774.svg) | (2S)-1-N-(5-Isoquinolin-6-yl-1,3,4-thiadiazol-2-yl)-3-[4-(trifluoromethyl)phenyl]propane-1,2-diamine | IC50 | 50.0 [1], 53.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_d796f4e542f2a04e363d9e300eb358a3.svg) | Oxindole-Based Inhibitor 57 | IC50 | 17.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_904bcdd4a336a26ce1c5b3cbed225f79.svg) | 4-[(2-Hydroxy-7-methyl-1H-indol-3-yl)methylideneamino]benzenesulfonamide | IC50 | 1000.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_80275fccaf482c61ca42d6e3277b53f9.svg) | Oxindole-Based Inhibitor 44 | IC50 | 10.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_c841964f4c3b3cbaf6e2ed4ff98eef94.svg) | Oxindole-Based Inhibitor 61 | IC50 | 2.1 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_be0d9ba594b18bc0275aa2729d548cca.svg) | 4-[[2-Hydroxy-4-(hydroxymethyl)-1H-indol-3-yl]methylideneamino]benzenesulfonamide | IC50 | 54.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_d9eae9d8c48a5b7def12c6be38d3f58a.svg) | 4-[1-(5-Chloro-2-hydroxy-1H-indol-3-yl)ethylideneamino]benzenesulfonamide | IC50 | 22.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_188287dcd4205d8ea9c40b9ac652fe0c.svg) | 4-[[5-(Methoxycarbonyl)-2-oxoindoline-3-ylidenemethyl]amino]benzenesulfonamide | IC50 | 2.1 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_778b623f2d883055f04243ae4606464f.svg) | 4-[[2-Hydroxy-6-(hydroxymethyl)-1H-indol-3-yl]methylideneamino]benzenesulfonamide | IC50 | 61.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_bbb022e35b51e0dcf62d24e1be076072.svg) | Oxindole-Based Inhibitor 40 | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_d2ec270719c1bb771bdbae675a28fd52.svg) | Oxindole-Based Inhibitor 17 | IC50 | 120.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_f89b196cfb5f00904756c0f20da60f20.svg) | Oxindole-Based Inhibitor 25 | IC50 | 4.6 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_b00338cc7b797408267977af69f388c5.svg) | Oxindole-Based Inhibitor 26 | IC50 | 7.9 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_3d23c6742629b6076f81428b3fdfb6a7.svg) | Oxindole-Based Inhibitor 28 | IC50 | 1.2 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_c8cac26fb863ff48d45892b165f7b52d.svg) | Oxindole-Based Inhibitor 30 | IC50 | 93.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_01bffc90a03028afd19a7674c36356e7.svg) | Oxindole-Based Inhibitor 32 | IC50 | 13.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_7d905330d55a9982ed47a7f8b8a9edb7.svg) | Oxindole-Based Inhibitor 35 | IC50 | 12.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_19ab918bcb575e2c228e5a3f27e60bc6.svg) | Oxindole-Based Inhibitor 36 | IC50 | 19.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_907fbebd5c4254018b0d179348ad50a3.svg) | Oxindole-Based Inhibitor 39 | IC50 | 2400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_108113d1e89b8f4d508dd6379a0400da.svg) | Oxindole-Based Inhibitor 41 | IC50 | 34.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_7b90ca17f9feedc90df2b6b372636c1d.svg) | Oxindole-Based Inhibitor 42 | IC50 | 11.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_c2deb678bc98caaa9fc4762386d231c5.svg) | Oxindole-Based Inhibitor 45 | IC50 | 12.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_5a2a1505117c287f619c2d6354f6938c.svg) | Oxindole-Based Inhibitor 46 | IC50 | 15.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_d5fc7b2b2d9b3e069fb6b5ff7e2e286a.svg) | 4-[(5-Amino-2-hydroxy-1H-indol-3-yl)diazenyl]benzenesulfonamide | IC50 | 74.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_1ac4e1a229de348144b50c9379d50ec6.svg) | Oxindole-Based Inhibitor 64 | IC50 | 43.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_e2cc3ad329f73c01fd9db5107fe9e0db.svg) | Oxindole-Based Inhibitor 65 | IC50 | 21.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_dedf69d7839a291394ccc41c36c35b5e.svg) | Oxindole-Based Inhibitor 69 | IC50 | 1000.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_a4e56096e120466e9bf0bbc6768aaa8a.svg) | Oxindole-Based Inhibitor 73 | IC50 | 13.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_2a03fb0542ba668f9032e170f651d4ef.svg) | Oxindole-Based Inhibitor 74 | IC50 | 54.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_3f4c98f421cae02e62ce58c27fafba8e.svg) | Oxindole-Based Inhibitor 75 | IC50 | 4.6 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_a5882a857c949d474577d2579d9f8828.svg) | 4-[(5-Chloro-2-hydroxy-7-methyl-1H-indol-3-yl)methylideneamino]benzenesulfonamide | IC50 | 1000.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_5432488500c91a9af54c9349078bffa3.svg) | 4-[(4-Imidazo[1,2-A]pyridin-3-ylpyrimidin-2-YL)amino]benzenesulfonamide | IC50 | 1.0 [1], 2.0 [2], 3.0 [3] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_e5f180cb91183e5912f41fad020a45c5.svg) | Benzofuranone deriv. 4 | IC50 | 1280.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_69f2c7877893833f480cd4f6243f6e29.svg) | Benzofuranone deriv. 5 | IC50 | 3970.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_c7d8aae6798986cc85299048c1752074.svg) | Benzofuranone deriv. 6 | IC50 | 310.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_a96bbe69cec288627265d90a1ea542e9.svg) | Benzofuranone deriv. 7 | IC50 | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_986db0437f20070dfb14143a9f1b018d.svg) | Dasatinib | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_af6c849cab29e175678bc52964f46c9c.svg) | Tofacitinib | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_b0aae8da0213ea09e5fa4e2429d9e2e7.svg) | Palbociclib | IC50 | 10.0 [1], 5000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_3a0159e99dc05924fc32ce9ebb42407b.svg) | Indazole | IC50 | 185000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_6ffe95ccc3fcbebfac071443c05490de.svg) | N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-YL)urea | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_26575b04a0a4cc9959845db9b7bd7b68.svg) | Purvalanol B | IC50 | 6.0 [1], 9.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_96721ecc39354291d9ab34e76c420543.svg) | Fascaplysin | IC50 | 500000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_9fb851793aa73d9e3bfe985893b8e689.svg) | 4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide | IC50 | 47.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_2de598172b9c7c6d2c3bb7d3509db05c.svg) | (16E)-14-Methyl-20-oxa-5,7,14,27-tetrazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaene | IC50 | 3.0 [1], 130.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_8030213d9f30efd3da30350a03e56f0d.svg) | PDGF Receptor Tyrosine Kinase Inhibitor IV | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_ff8d70c51ab004168316abca0032193b.svg) | 1-Tert-butyl-3-(naphthalen-1-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 5.0 [1], 29000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_757c9af7e3ada4de08a9d8b6499aee26.svg) | 1-(Tert-Butyl)-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 15.0 [1], 18000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_3b4965798e2b1bd29984cf789ef3e07a.svg) | 6-Aryl-pyrazolo[3,4-b]pyridine analogue 13 | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_33de0585ead6478c7b12faa9d2689d8f.svg) | N-[5-Bromo-6-(furan-2-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_01090a953164dd57cfdcc9c19e13bebc.svg) | Aristolactam AIIIa | IC50 | 140.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_ccf2cb0fa92fa4550145f26d2502cdf4.svg) | N-(6-Phenyl-1H-indazol-3-yl)cyclopropanecarboxamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_56cfed04f079fe9493d936ae3f588a07.svg) | Oxindole-Based Inhibitor 81 | IC50 | 1.6 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_61d81cba4d7ea43cbbd774d2d0bff36f.svg) | N-[6-(Furan-2-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_d62218b0765fec0222a4177e997f1351.svg) | N-[6-(3-Sulfamoylphenyl)-1H-indazol-3-yl]cyclopropanecarboxamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_6c38560dee3540f939fdaa0ff2c01d1d.svg) | N-(2-Chloro-6-methylphenyl)-2-[(2,6-dimethylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide | IC50 | 25000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_8d3a180fba930b02857665ebe0db700c.svg) | 4-[[5-(Isobutoxycarbonyl)-2-oxoindoline-3-ylidenemethyl]amino]benzenesulfonamide | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_d7d134482f5e61de6ab9d940f14582f1.svg) | Oxindole-Based Inhibitor 33 | IC50 | 21.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_7ca58fc7dd7007d668e192bd64c2d4ce.svg) | Oxindole-Based Inhibitor 58 | IC50 | 12.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_eba8b936b9cd30d2e7cb01c514a64e61.svg) | Oxindole-Based Inhibitor 59 | IC50 | 25.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_51f564fe4ea5a8352eedf76a87d2418b.svg) | Oxindole-Based Inhibitor 62 | IC50 | 6.8 [1] |
![](https://images.aatbio.com/dataset/ic50/cyclin-dependent-kinase-2_3ab9460b7e7b1792127981364b5a6a2c.svg) | N'-(Pyrrolidino[2,1-B]isoindolin-4-ON-8-YL)-N-(pyridin-2-YL)urea | IC50 | 80.0 [1], 440.0 [2] |